Team:Toulouse/Result/experimental-results

From 2014.igem.org

(Difference between revisions)
Line 134: Line 134:
<p class="title3">Tests with commercial peptides and controls
<p class="title3">Tests with commercial peptides and controls
</p>
</p>
-
<p class="texte">The first tests were accomplished with commercial GAFP-1 and D4E1 peptides at different concentrations (2,5µM/12,5µM/25µM/100µM). These tests were performed on different fungal strains sharing the same phylum with <i>Ceratocystis Platani</i>.</br>
+
<p class="texte">The first tests were accomplished with commercial GAFP-1 and D4E1 peptides at different concentrations (12,5µM/25µM/100µM). These tests were performed on different fungal strains sharing the same phylum with <i>Ceratocystis Platani</i>.</br>
As <i>Ceratocystis Platani</i> is pathogenic, we could not perform tests directly with this fungus.</br>
As <i>Ceratocystis Platani</i> is pathogenic, we could not perform tests directly with this fungus.</br>
After several days at 30°C, the PDA (Potato Dextrose Agar) plates couvered with fungus and commercial peptides were analyzed.
After several days at 30°C, the PDA (Potato Dextrose Agar) plates couvered with fungus and commercial peptides were analyzed.

Revision as of 14:53, 9 October 2014